Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2295315 | 0.82 | ALDH1A1 (0.47) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL377540 | 0.81 | ALDH1A1 (0.57) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL7962929 | 0.81 | ALDH1A1 (0.50) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL18868411 | 0.80 | ALDH1A1 (0.46) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL135646 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL14342701 | 0.79 | L3MBTL1 (0.33) | ALDH1A1 | |
| SCHEMBL9314831 | 0.78 | MGLL (0.49) | ALDH1A1MGLL | |
| SCHEMBL4117931 | 0.77 | CA2 (0.47) | ALDH1A1 | |
| SCHEMBL13651147 | 0.77 | CA2 (0.47) | ALDH1A1 | |
| SCHEMBL16340361 | 0.77 | ALDH1A1 (0.53) | ALDH1A1TP53CYP3A4MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100168851-A1 | Surface Modified Biomedical Devices | ISTA PHARMACEUTICALS | 2010-07-01 | — | — | US | claimed |
| WO-2009085759-A1 | SEGMENTED REACTIVE BLOCK COPOLYMERS | BAUSCH & LOMB INCORPORATED (US) | 2009-07-09 | — | — | WO | claimed |
| US-20090171049-A1 | SEGMENTED REACTIVE BLOCK COPOLYMERS | BAUSCH & LOMB INCORPORATED | 2009-07-02 | — | — | US | claimed |
| EP-1572261-B1 | SURFACE TREATMENT OF MEDICAL DEVICE | BAUSCH & LOMB (US) | 2008-07-30 | — | — | EP | claimed |
| US-6958169-B2 | Surface treatment of medical device | BAUSCH & LOMB INCORPORATED (US) | 2005-10-25 | — | — | US | claimed |
| EP-1572261-A1 | SURFACE TREATMENT OF MEDICAL DEVICE | BAUSCH & LOMB INCORPORATED (US) | 2005-09-14 | — | — | EP | claimed |
| WO-2004060431-A1 | SURFACE TREATMENT OF MEDICAL DEVICE | BAUSCH & LOMB INCORPORATED (US) | 2004-07-22 | — | — | WO | claimed |
| US-20040116310-A1 | Surface treatment of medical device | BAUSCH & LOMB INCORPORATED | 2004-06-17 | — | — | US | claimed |
| WO-2003057896-A1 | METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | claimed |
| WO-2003057687-A1 | METHODS FOR PREPARING DOXORUBICIN DERIVATIVES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | claimed |
| US-20240240047-A1 | BIOMEDICAL DEVICES HAVING A SURFACE COATING | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-07-18 | — | — | US | disclosed |
| WO-2024146878-A1 | BIOMEDICAL DEVICES HAVING A SURFACE COATING | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-07-11 | — | — | WO | disclosed |
| EP-4396627-A1 | OPHTHALMIC DEVICES AND METHOD OF MANUFACTURING | Bausch + Lomb Ireland Limited (IE) | 2024-07-10 | — | — | EP | disclosed |
| EP-4396626-A1 | OPHTHALMIC DEVICES AND METHOD OF MANUFACTURING | Bausch + Lomb Ireland Limited (IE) | 2024-07-10 | — | — | EP | disclosed |
| EP-3917837-B1 | PACKAGING SOLUTIONS FOR CONTACT LENSES | BAUSCH & LOMB (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-1572261-A1 | SURFACE TREATMENT OF MEDICAL DEVICE | BAUSCH & LOMB INCORPORATED (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004060431-A1 | SURFACE TREATMENT OF MEDICAL DEVICE | BAUSCH & LOMB INCORPORATED (US) | 2004-07-22 | — | — | WO | disclosed |
| US-20040116310-A1 | Surface treatment of medical device | BAUSCH & LOMB INCORPORATED | 2004-06-17 | — | — | US | disclosed |
| WO-2003057687-A1 | METHODS FOR PREPARING DOXORUBICIN DERIVATIVES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| WO-2003057896-A1 | METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | disclosed |